Week's top
Latest news
Unread news
Subscribe

Science X Account

Remember me

Click here to sign in with or

Forget Password?

Not a member? Sign up

Addiction
Alzheimer's disease & dementia
Arthritis & Rheumatism
Attention deficit disorders
Autism spectrum disorders
Biomedical technology
Cardiology
Dentistry
Diabetes
Diseases, Conditions, Syndromes
Endocrinology & Metabolism
Gastroenterology

Genetics
Gerontology & Geriatrics
Health
Health informatics
HIV & AIDS
Immunology
Inflammatory disorders
Medical economics
Medical research
Medications
Neuroscience
Obstetrics & gynaecology

Oncology & Cancer
Ophthalmology
Other
Overweight & Obesity
Parkinson's & Movement disorders
Pediatrics
Psychology & Psychiatry
Radiology & Imaging
Sleep disorders
Sports medicine & Kinesiology
Surgery
Vaccination

Asthma
Breast cancer
Cardiovascular disease
Chronic obstructive pulmonary disease
Colon cancer
Coronary artery disease

Dementia
Depression
Heart attack
Heart disease
High blood pressure
Influenza

Kidney disease
Leukemia
Lung cancer
Malaria
Melanoma
Multiple sclerosis

Myocardial infarction
Ovarian cancer
Post traumatic stress disorder
Rheumatoid arthritis
Schizophrenia
Skin cancer

Stroke
Type 2 diabetes
Full List »

Home
Archive
22/04/2021

Archive: 22/04/2021

'Breakthrough' COVID infections after vaccination very rare: study

(HealthDay)—COVID-19 "breakthrough" infections, where someone who's been fully vaccinated becomes infected nonetheless, are exceedingly rare, a new study suggests.

Apr 22, 2021

0

7

How to make sure everyone gets a fair shot at the COVID-19 vaccine

Getting vaccinated may be everyone's best protection against COVID-19. But giving everyone fair access to vaccines will take more than just providing needles and vials, community health experts say.

Apr 22, 2021

0

6

India's COVID-19 surge and the new variant: what we know

India is battling a record-breaking rise in COVID-19 infections that has overwhelmed hospitals and led to severe bed and oxygen shortages.

Apr 22, 2021

0

16

Recovered but RT-PCR-positive individuals unlikely to transmit SARS-CoV-2

(HealthDay)—Individuals who have clinically recovered from severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection and continue to test positive for viral RNA after completing the recommended isolation period ...

Apr 22, 2021

0

3

MERS DNA vaccine induces immunity, protects from virus challenge in preclinical model

A synthetic DNA vaccine candidate for Middle East respiratory syndrome coronavirus (MERS-CoV) developed at The Wistar Institute induced potent immune responses and afforded protective efficacy in non-human primate (NHP) models ...

Apr 22, 2021

0

29

Researchers identify predictive factors of delirium in Sub-Saharan Africa

Severity of illness, history of stroke, and being divorced or widowed were independently predictive of delirium in hospitalized patients in Zambia, according to a study published in PLOS ONE.

Apr 22, 2021

0

3

COVID-19 vaccine development built on $17 billion in NIH funding for vaccine technologies

The unprecedented development of COVID-19 vaccines less than a year after discovery of this virus was enabled by more than $17 billion of research on vaccine technologies funded by the NIH prior to the pandemic, according ...

Apr 22, 2021

0

3

Among COVID-19 survivors, an increased risk of death, serious illness

As the COVID-19 pandemic has progressed, it has become clear that many survivors—even those who had mild cases—continue to manage a variety of health problems long after the initial infection should have resolved. In ...

Apr 22, 2021

0

431

During pandemic's first 9 months, depression and anxiety increased sharply among Americans

Confirming anecdotal evidence that the spread of the coronavirus has strained Americans' mental health, Boston College researchers found reports of anxiety increased to 50 percent and depression to 44 percent by November, ...

Apr 22, 2021

0

5

Less is more for the next generation of CAR T cells

When researchers from Penn Medicine found that many patients with B-cell acute lymphoblastic leukemia (ALL) treated with the investigational chimeric antigen receptor (CAR) T cell therapy targeting the CD22 antigen didn't ...

Apr 22, 2021

0

72

page 3 from 11

«
»

Phys.org — Phys.org

Daily science news on research developments and the latest scientific innovations

Tech Xplore

The latest engineering, electronics and technology advances

ScienceX — Science X

The most comprehensive sci-tech news coverage on the web

Newsletters

Science X Daily and the Weekly Email Newsletter are free features that allow you to receive your favorite sci-tech news updates in your email inbox

Follow us

Top
Home
Search
Mobile version

Help
FAQ
About
Contact

Science X Account
Premium Account
Newsletter
Archive

Android app
iOS app
RSS feeds
Push notification

© Medical Xpress 2011 - 2024 powered by Science X Network

Privacy policy Terms of use Medical Disclaimer

E-mail newsletter

Follow us